Literature DB >> 18388666

Does the proximity of an amputation, length of time between foot ulcer development and amputation, or glycemic control at the time of amputation affect the mortality rate of people with diabetes who undergo an amputation?

Richard N Jones1, William P Marshall.   

Abstract

OBJECTIVES: The main purpose of the authors' research was to compare the 3- and 5-year mortality rates of diabetic patients who have undergone a lower-extremity amputation, evaluating the proximity of the amputation in 3 groups (toe and foot amputation, BKA, and AKA), the timing of the amputation (within or after 2 years of the onset of the foot ulcer), and the effect of glycemic control at the time of amputation, regardless of the level of amputation. METHODS AND
DESIGN: The subjects were 80 male inpatients at Illiana Veterans Health Care System who had diabetes, diabetic neuropathy, peripheral vascular disease, and a diabetic foot ulcer that resulted in an amputation. Of the 80 patients, 29 had a toe amputation, 30 had a BKA, and 21 had an AKA. The mean age in all 3 groups was 68.5 years+/-7.2 years. The authors used the hemoglobin A1C (Hgb A1C) level to assess glycemic control. MAIN OUTCOME MEASURES: Several chi tests were used to compare the 3- and 5-year mortality rates among the amputation groups. An Hgb A1C level of 8% or less defined good glycemic control; an Hgb A1C level of more than 8% defined poor glycemic control. A chi test was used to compare glycemic control, the level of amputation, and the mortality rate. A chi test was also used to evaluate the length of time between ulcer formation and amputation, the level of amputation, and the mortality. All statistics were done using SPSS 10.0 student version.
CONCLUSIONS: The research revealed a statistically significant difference in mortality among the 3 groups at 3 and 5 years. No statistically significant difference in mortality in patients with good glycemic control and patients with bad glycemic control was found. At 3 years, a statistically significant difference in mortality existed between patients who had an amputation within 2 years of ulcer formation and those who had an amputation after 2 years. At 5 years, no statistically significant difference existed between these 2 groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388666     DOI: 10.1097/01.ASW.0000305419.73597.5f

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  5 in total

1.  The effect of monochromatic infrared energy on diabetic wound healing.

Authors:  Yayi He; Selina Ly Yip; Kwok-Kuen Cheung; Lin Huang; Shijie Wang; Gladys Ly Cheing
Journal:  Int Wound J       Date:  2012-07-09       Impact factor: 3.315

2.  Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China.

Authors:  Yue-Jie Chu; Xi-Wen Li; Peng-Hua Wang; Jun Xu; Hao-Jie Sun; Min Ding; Jiao Jiao; Xiao-Yan Ji; Shu-hong Feng
Journal:  Int Wound J       Date:  2014-03-14       Impact factor: 3.315

3.  Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series.

Authors:  Kenneth Blum; Amanda Lh Chen; Thomas Jh Chen; B William Downs; Eric R Braverman; Mallory Kerner; Stella Savarimuthu; Anish Bajaj; Margaret Madigan; Seth H Blum; Gary Reinl; John Giordano; Nicholas Dinubile
Journal:  Cases J       Date:  2010-02-10

4.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

Review 5.  Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources.

Authors:  Michael P Dillon; Matthew Quigley; Stefania Fatone
Journal:  Syst Rev       Date:  2017-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.